Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Jul 22;8(1):7-11.
doi: 10.1016/j.chom.2010.06.005.

Inflammasome inhibition as a pathogenic stealth mechanism

Affiliations
Review

Inflammasome inhibition as a pathogenic stealth mechanism

Debra J Taxman et al. Cell Host Microbe. .

Abstract

The activation of inflammasomes containing NBD-LRR (NLRs) or non-NLRs is critical for effective host defense against microbial pathogens. Recent discoveries have uncovered a plethora of pathogenic strategies to inhibit inflammasome-mediated processing of IL-1beta and IL-18. We review recent evidence for viral and bacterial manipulation of the inflammasome, ranging from perturbation of caspase-1 activation to targeting of specific inflammasome components.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Suppression of the two step regulation of IL-1β production by virus and bacteria
Host IL-1β release is prompted by a two step process. First, the activation of NF-κB and AP-1 leads the transcription of pro-IL-1β. A second signal sensed by an NLR triggers the assembly of the inflammasome and the subsequent activation of caspase-1. Active caspase-1 proteolytically processes pro-IL-1β into IL-1β for release. Viruses and bacteria have developed an array of strategies to interfere with inflammasome activation. Myxoma and Shope fibroma viruses utilize POP-like proteins M013 and gp013L to bind ASC/PYCARD and prevent the inflammasome assembly. Poxviruses also express the serpins crmA, Serp2, B13L, and SPI-2 which disrupt the proteolytic activity of caspase-1, potentially through direct binding to caspase-1. Influenza A virus and baculovirus express NS1 and p35, and Y. enterocolitica expresses Yop E and YopT that disrupt caspase-1 oligomerization.. The P. aeruginosa effector molecules ExoU and ExoS block the activation of the NLRC4 inflammasome, while the Mycobacterium tuberculosis gene zmp1 may target the NLRP3 inflammasome. Pneumolysin of Streptococcus pneumonia also blocks IL-1β release by diminishing caspase-1 activity. YopK of Yersinia pseudotuberculosis has a unique mechanisms in that it binds to T3SS and masks detection by the inflammasome Though each of these proteins inhibits caspase-1 activation, it is not known in most cases whether caspase-1 is directly targeted or whether effects are mediated indirectly by targeting of an upstream regulator.

References

    1. Bedoya F, Sandler LL, Harton JA. Pyrin-only protein 2 modulates NF-kappaB and disrupts ASC:CLR interactions. J Immunol. 2007 Mar 15;178(6):3837–45. - PubMed
    1. Brodsky IE, Palm NW, Sadanand S, Ryndak MB, Sutterwala FS, Flavell RA, Bliska JB, Medzhitov R. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe. 2010 May 20;7(5):376–87. - PMC - PubMed
    1. Bruey JM, Bruey-Sedano N, Luciano F, Zhai D, Balpai R, Xu C, Kress CL, Bailly-Maitre B, Li X, Osterman A, Matsuzawa S, Terskikh AV, Faustin B, Reed JC. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1. Cell. 2007 Apr 6;129(1):45–56. - PubMed
    1. Bump NJ, Hackett M, Hugunin M, Seshagiri S, Brady K, Chen P, Ferenz C, Franklin S, Ghayur T, Li P. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science. 1995 Sep 29;269(5232):1885–8. - PubMed
    1. Cordoba-Rodriguez R, Fang H, Lankford CS, Frucht DM. Anthrax lethal toxin rapidly activates caspase-1/ICE and induces extracellular release of interleukin (IL)-1beta and IL-18. J Biol Chem. 2004 May 14;279(20):20563–6. - PubMed

Publication types